# Opko Health

Type: Company (OPK)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/opko-health
Canonical HTML page: https://gethealthbrief.com/entity/opko-health

## Recent coverage (1 stories)

### Opko Health Jumps 33% as Pharma Revenue Doubles to $89M
2026-07-29 00:08:14 · Sentiment: Very Bullish · Impact: 6/10 · Sources: 3

Opko Health's stock soared after Q2 earnings dramatically exceeded forecasts, with pharmaceutical revenue more than doubling year-over-year. The company's strategic pivot away from oncology is paying off, as it raised full-year revenue guidance to $560-$585 million and narrowed its net loss to just $8.4 million. For healthcare investors and providers, the results signal a successful refocusing on core therapeutic areas.
Full story: https://gethealthbrief.com/story/opko-health-surges-33-pharma-revenue-doubles

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.